Luteal-phase defect.
Cook CL.
Clin Obstet Gynecol. 1991 Mar;34(1):198-210. doi: 10.1097/00003081-199103000-00022.
The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review.
Muneeba S Jr, Acharya N, Mohammad S.
Cureus. 2023 Nov 3;15(11):e48194. doi: 10.7759/cureus.48194. eCollection 2023 Nov.
Luteal phase defect: a review of pathophysiology.
Jones GS.
Curr Opin Obstet Gynecol. 1991 Oct;3(5):641-8.
Luteal phase defect.
March CM, Mishell DR Jr, McNeile LG.
Fertil Steril. 1990 Jan;53(1):189-90. doi: 10.1016/s0015-0282(16)53246-4.
Luteal phase defect: myth or reality.
Bukulmez O, Arici A.
Obstet Gynecol Clin North Am. 2004 Dec;31(4):727-44, ix. doi: 10.1016/j.ogc.2004.08.007.
Premenstrual syndrome: A mini review.
Ryu A, Kim TH.
Maturitas. 2015 Dec;82(4):436-40. doi: 10.1016/j.maturitas.2015.08.010. Epub 2015 Aug 28.
Luteal phase defect. Etiology, diagnosis, and management.
Ginsburg KA.
Endocrinol Metab Clin North Am. 1992 Mar;21(1):85-104.
[Luteal phase defect].
Sugino N.
Nihon Rinsho. 2006 Apr;64 Suppl 4:440-6.
Luteal Phase Defects and Progesterone Supplementation.
Collins LC, Gatta LA, Dotters-Katz SK, Kuller JA, Schust DJ.
Obstet Gynecol Surv. 2024 Feb;79(2):122-128. doi: 10.1097/OGX.0000000000001242.
Hotspots and frontiers in luteal phase defect research: An in-depth global trend bibliometric and visualization analysis over a 52-year period.
Shi L, Cui L, Yang L, He L, Jia L, Bai W, Wang L, Xu W.
Heliyon. 2024 Jul 25;10(15):e35088. doi: 10.1016/j.heliyon.2024.e35088. eCollection 2024 Aug 15.
